ConductScience.org, home

Paper7797604

Formestane: an effective first-line endocrine treatment for advanced breast cancer.

Zilembo N and 9 others. J Cancer Res Clin Oncol, 1995. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Formestane: an effective first-line endocrine treatment for advanced breast cancer. Papers, record 7797604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7797604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Formestane: an effective first-line endocrine treatment for advanced breast cancer.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2025-07-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zilembo NN
2Bajetta EE
3Noberasco CC
4Buzzoni RR
5Vicario GG
6Bono AA
7Laffranchi AA
8Biasi GG
9Dolci SS
10Bichisao EE

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AndrostenedioneMajor topic
Antineoplastic AgentsMajor topic
Aromatase InhibitorsMajor topic
Breast NeoplasmsMajor topic
17-Hydroxycorticosteroids
Aged
Drug Administration Schedule
Estradiol
Female
Humans
Injections, Intramuscular
Middle Aged
Postmenopause
Prognosis
Risk Factors
Survival Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12900646Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.Br J Cancer1988https://conductscience.org/library/papers/2900646PubMed
21498070Towards a molecular basis for tamoxifen resistance in breast cancer.Ann Oncol1992https://conductscience.org/library/papers/1498070PubMed
33061640Antioestrogens in the management of hormone-dependent cancer.Cancer Treat Rev1988https://conductscience.org/library/papers/3061640PubMed
41995354A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients.Eur J Surg Oncol1991https://conductscience.org/library/papers/1995354PubMed
57873457Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.Ann Oncol1994https://conductscience.org/library/papers/7873457PubMed
62644532A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.N Engl J Med1989https://conductscience.org/library/papers/2644532PubMed
77507033Tamoxifen as adjuvant therapy in breast cancer. Current status.Drugs1993https://conductscience.org/library/papers/7507033PubMed
82885637Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.Lancet1987https://conductscience.org/library/papers/2885637PubMed
96851305Primary treatment of breast cancer in elderly women with Tamoxifen.Clin Oncol1983https://conductscience.org/library/papers/6851305PubMed
108018527Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.Br J Cancer1994https://conductscience.org/library/papers/8018527PubMed
11912660Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.Cancer1977https://conductscience.org/library/papers/912660PubMed
122259926Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program.Semin Oncol1990https://conductscience.org/library/papers/2259926PubMed
132322991Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2322991PubMed
142144154Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme.Eur J Cancer1990https://conductscience.org/library/papers/2144154PubMed
153917820Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3917820PubMed
163123050Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.Cancer Res1988https://conductscience.org/library/papers/3123050PubMed
172900647Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.Br J Cancer1988https://conductscience.org/library/papers/2900647PubMed
187902904Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.Lancet1993https://conductscience.org/library/papers/7902904PubMed
191531483The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.J Clin Endocrinol Metab1992https://conductscience.org/library/papers/1531483PubMed
2014192854-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer.Eur J Cancer1992https://conductscience.org/library/papers/1419285PubMed

See all 26 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7797604

GET https://conductscience.org/api/papers/v1/7797604/references?page=2